Elizabeth Cho-Fertikh, PhD
Washington, District of Columbia, United States
3K followers
500 connections
Washington, District of Columbia, United States
3K followers
500 connections
About
My current healthcare advisory & investment activities represent the sum of my 25 years…
Articles by Elizabeth
-
Carillon Biopharma news: UW wins national nanotechnology startup challenge for breast cancer treatment
Carillon Biopharma news: UW wins national nanotechnology startup challenge for breast cancer treatment
By Elizabeth Cho-Fertikh, PhD
-
MD-based biotech: cancer scientist position open
MD-based biotech: cancer scientist position open
By Elizabeth Cho-Fertikh, PhD
-
ECF BIO selected a winner of the 2016 NIH/CAI Cancer Nanotech Challenge
ECF BIO selected a winner of the 2016 NIH/CAI Cancer Nanotech Challenge
By Elizabeth Cho-Fertikh, PhD
Activity
-
Colleagues, A few pieces of exciting news… First, I’m thrilled to share that I’ve joined Lynn Fiellin, MD and Anusha Raja, MD at Playbl, Inc., a…
Colleagues, A few pieces of exciting news… First, I’m thrilled to share that I’ve joined Lynn Fiellin, MD and Anusha Raja, MD at Playbl, Inc., a…
Liked by Elizabeth Cho-Fertikh, PhD
-
Tune in to #NewsMax: thoughts from my Co-Managing Partner at MEDA Ventures on potential #economic topics to come up in tonight's #Presidential…
Tune in to #NewsMax: thoughts from my Co-Managing Partner at MEDA Ventures on potential #economic topics to come up in tonight's #Presidential…
Shared by Elizabeth Cho-Fertikh, PhD
-
We’re thrilled to announce that we have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for our ECG-AF device that uses AI…
We’re thrilled to announce that we have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for our ECG-AF device that uses AI…
Liked by Elizabeth Cho-Fertikh, PhD
Experience
-
MEDA Ventures
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
Volunteer Experience
-
Science Business Mentor
Johns Hopkins Ventures & Halcyon Incubator Ventures
- Present 12 years 7 months
Science and Technology
Publications
-
"Methylation at lysine 4 of histone H3 in ecdysone-dependent development of Drosophila"
-
NATURE: 426 (6962), 78-83, 2003
Other authors -
-
"Modulation of heat shock gene expression by the TAC1 chromatin modifying complex"
-
NATURE CELL BIO, 6 (2), 162-7, 2004
Other authors -
-
“Biology of Adult Mesenchymal Stem Cells: Regulation of Niche, Self-Renewal And Differentiation”
-
ARTHRITIS RES THER: 19;9 (1) : 204, 2007 .
Other authors -
-
18 others
-
-
White papers for NIH/National Children's Study
-
-Ethics of Return of Individual Genomics Results, 6/12
-Ancestral Informative Markers and Disease Propensity, 6/12
-Autism Update, 10/11
-Regulatory RNAs, 5/11
-Biospecimen QA for Genetic & Epigenetic Studies, 4/10
Languages
-
English
Native or bilingual proficiency
-
French
Professional working proficiency
Organizations
-
naisA Global
Chair, Fundraising Committee
- Present
More activity by Elizabeth
-
Learn about #SurVaxM and #GBM at www.mimivax.com & check out our new animated mechanism of action video below. MimiVax, Inc. Sheila Figel
Learn about #SurVaxM and #GBM at www.mimivax.com & check out our new animated mechanism of action video below. MimiVax, Inc. Sheila Figel
Liked by Elizabeth Cho-Fertikh, PhD
-
The Brain Tumor Investment Fund (BTIF) is a mission-driven venture philanthropy fund that relies on the generosity of philanthropic donors to fuel…
The Brain Tumor Investment Fund (BTIF) is a mission-driven venture philanthropy fund that relies on the generosity of philanthropic donors to fuel…
Liked by Elizabeth Cho-Fertikh, PhD
-
Investors: a great online conference!! #GPs #LPs #FoF #FundofFunds #Generalpartners #Limitedpartners
Investors: a great online conference!! #GPs #LPs #FoF #FundofFunds #Generalpartners #Limitedpartners
Shared by Elizabeth Cho-Fertikh, PhD
-
43North - Geographic Distribution of Investments In 2014, 43North was founded to play a role in Buffalo’s rebirth, serving as a catalyst for startup…
43North - Geographic Distribution of Investments In 2014, 43North was founded to play a role in Buffalo’s rebirth, serving as a catalyst for startup…
Liked by Elizabeth Cho-Fertikh, PhD
-
Precision medicine has rapidly changed the oncology field. The FDA has approved both gene- and immune-targeted drugs for tissue-agnostic, genomic…
Precision medicine has rapidly changed the oncology field. The FDA has approved both gene- and immune-targeted drugs for tissue-agnostic, genomic…
Liked by Elizabeth Cho-Fertikh, PhD
-
After years of speculation and over $1.3 billion in raised capital, Tempus AI is at last set to go public. The precision medicine company has…
After years of speculation and over $1.3 billion in raised capital, Tempus AI is at last set to go public. The precision medicine company has…
Liked by Elizabeth Cho-Fertikh, PhD
-
I'm honored to speak on behalf of HealthTech 4 Medicaid, an organization with a great mission and one I respect and admire. I also get to talk about…
I'm honored to speak on behalf of HealthTech 4 Medicaid, an organization with a great mission and one I respect and admire. I also get to talk about…
Liked by Elizabeth Cho-Fertikh, PhD
-
Our portfolio company, MimiVax, Inc. , granted orphan drug designation for ALL brain gliomas for their cancer vaccine. Expanded market…
Our portfolio company, MimiVax, Inc. , granted orphan drug designation for ALL brain gliomas for their cancer vaccine. Expanded market…
Shared by Elizabeth Cho-Fertikh, PhD
-
MimiVax, Inc. was awarded our second Orphan Drug Designation for #SurVaxM. Expanding coverage from our previous designation of glioblastoma to now…
MimiVax, Inc. was awarded our second Orphan Drug Designation for #SurVaxM. Expanding coverage from our previous designation of glioblastoma to now…
Liked by Elizabeth Cho-Fertikh, PhD
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More